The Chemistry Behind ADCs
Combining the selective targeting of tumor cells through antigen-directed recognition and potent cell-killing by cytotoxic payloads, antibody-drug conjugates (ADCs) have emerged in recent years as an efficient therapeutic approach for the treatment of various cancers. Besides a number of approved dr...
Saved in:
Main Authors: | Vesela Kostova (Author), Patrice Désos (Author), Jérôme-Benoît Starck (Author), Andras Kotschy (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemistry Behind the Immunomodulatory Activity of Astragalus membranaceus
by: Mallique Qader, et al.
Published: (2021) -
New antibody-drug conjugates (ADCs) in breast cancer-an overview of ADCs recently approved and in later stages of development
by: Kira-Lee Koster, et al.
Published: (2022) -
Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)-A Necessity for Future ADC Research and Development
by: Manar Hammood, et al.
Published: (2021) -
Ponatinib: A Review of the History of Medicinal Chemistry behind Its Development
by: Mayara Nascimento, et al.
Published: (2024) -
The Analysis of Key Factors Related to ADCs Structural Design
by: Haichao Tang, et al.
Published: (2019)